Patricio Garino

FF
Free Agent
Done for season
FZalgiris Kaunas
Hamstring
May 12, 2021
Garino will miss the rest of the season with a torn hamstring, according to Donatas Urbonas of 15min.lt.
ANALYSIS
Garino already missed a couple extended periods of action this season, first while recovering from knee surgery and then due to COVID-19, and his latest issue will bring his season to an early end. It's not clear how long Garino will need to recover, so it remains to be seen if he will be ready to go for the beginning of next season.
Read More News
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
EuroLeague Total Stats
Loading Total Stats...
EuroLeague Per 36 Stats
Loading Per 36 Stats...
2020
2019
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
More Fantasy News
Tests positive for COVID-19
FZalgiris Kaunas
Illness
April 13, 2021
Zalgiris announced Tuesday that Garino has tested positive for COVID-19.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Set to play Thursday
FZalgiris Kaunas
March 25, 2021
Garino will be available for Thursday's game against Maccabi, according to euroleague.net.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Game-time decision Thursday
FZalgiris Kaunas
Rest
March 24, 2021
Garino will be a game-time decision for Thursday's game against Maccabi, according to Zalgiris' official website.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Sees first action since October
FZalgiris Kaunas
March 23, 2021
Garino (knee) made his first appearance since October in Tuesday's domestic game and put up three points and two rebounds over 14 minutes off the bench.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Remains sidelined
FZalgiris Kaunas
Knee
March 12, 2021
Garino (knee) will not play Friday against Efes, according to euroleague.net.
ANALYSIS
Subscribe now to instantly reveal our take on this news.